MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3
出版年份 2013 全文链接
标题
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3
作者
关键词
Pancreatic cancer, MicroRNAs, Apoptosis, Metastasis, Cell cycle and cell division, Prognosis, Cell proliferation, Transfection
出版物
PLoS One
Volume 8, Issue 9, Pages e73803
出版商
Public Library of Science (PLoS)
发表日期
2013-09-11
DOI
10.1371/journal.pone.0073803
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
- (2012) P Dong et al. ONCOGENE
- Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
- (2012) Xiwei Wu et al. PLoS One
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
- (2012) Angela M Liu et al. BMJ Open
- MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma
- (2011) Linwah Yip et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells
- (2011) Sanjeev K. Srivastava et al. CARCINOGENESIS
- SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells
- (2011) G Zhao et al. GENE THERAPY
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
- (2011) Chun Yang et al. GYNECOLOGIC ONCOLOGY
- Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma
- (2011) Johanna B. Munding et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice
- (2011) Hai dong Li et al. PLoS One
- MicroRNAs in the Pathogenesis of Cancer
- (2011) Francesca Lovat et al. SEMINARS IN ONCOLOGY
- microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
- (2010) J Zhang et al. BRITISH JOURNAL OF CANCER
- miR-146a Suppresses Invasion of Pancreatic Cancer Cells
- (2010) Y. Li et al. CANCER RESEARCH
- MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer
- (2010) Kin Wai Lai et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-20a Overexpression Inhibited Proliferation and Metastasis of Pancreatic Carcinoma Cells
- (2010) Haijiao Yan et al. HUMAN GENE THERAPY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer
- (2009) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion
- (2009) Guang Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor -Mediated Invasion and Metastasis in Pancreatic Cancer Cells
- (2008) S. Zhao et al. CANCER RESEARCH
- STAT3 expression in gastric cancer indicates a poor prognosis
- (2008) Dae-Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia
- (2008) D Schotte et al. LEUKEMIA
- MicroRNA in Cancer Prognosis
- (2008) Frank J. Slack et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now